ARPM: Russian pharma industry achievements are also those of the medical community

7 July 2017

A conference on the role of the Russian professional medical community in healthcare development, which was dedicated to the 10th anniversary of the Association of Clinical Pharmacologists of Saint-Petersburg, took place earlier this week.

The main goal of this scientific conference, organized by the Association was to increase the professional level of doctors and to optimize the provision of medicines for the privileged categories of citizens at the regional level.

Speaking about the achievements of the Russian pharmaceutical industry, Viktor Dmitriev, a general director of the trade group Association of Russian Pharmaceutical Manufacturers (ARPM), noted that these achievements also belong to the medical community. According to the results for 2016, the value of the pharmaceutical market was $19.370 billion, which is 2.2% of the world market.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK